Investment
Features
FeesSafety
Academy
More
Pluang+

CLARITY Act stalls in Senate over crypto rules; Bitcoin falls 22% from May peak

Market News
13 Jul 2026
Crypto Briefing
View Source
Bearish
pluang ai news

The CLARITY Act, a key U.S. cryptocurrency regulation bill, is stalled in the Senate due to disagreements over restrictions on officeholders, with Senator Warren pushing for specific rules opposed by the White House. Despite this, major market structure provisions favored by firms like Coinbase and Circle have been agreed upon. Bitcoin's price has dropped 22% from its May high of $80,000 amid the legislative uncertainty. Observers are watching for a third Democratic senator to support the bill, which could help break the deadlock before the August recess.

More News

AI use in cybersecurity jumps to 78% in 2026, but governance and failures lag behind.

AI use in cybersecurity jumps to 78% in 2026, but governance and failures lag behind.

The 2026 SANS AI Survey reveals rapid AI adoption in cybersecurity, with 78% of organizations using AI, up from 50% last year. However, governance structures and formal audit frameworks have not kept pace, leading to increased AI-related failures in ...

Market News
Neutral
1 hour ago
Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.

Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.

The head and neck squamous cell carcinoma (HNSCC) market is projected to grow at a 10.5% CAGR from 2026 to 2036, driven by rising cancer incidence and new immunotherapy launches. Key emerging therapies from companies like Johnson & Johnson, BioNTech,...

Market News
Bullish
3 hours ago
Noble Capital Markets starts coverage on VivoPower with Outperform rating and $10 target

Noble Capital Markets starts coverage on VivoPower with Outperform rating and $10 target

Noble Capital Markets has initiated equity research coverage on VivoPower PLC, assigning an Outperform rating and setting a price target of $10. VivoPower is a B Corp-certified global developer of powered land and data center infrastructure for AI ap...

Analyst Insights
Bullish
3 hours ago
Alamar Biosciences launches national study using blood tests to advance Alzheimer's biomarker research.

Alamar Biosciences launches national study using blood tests to advance Alzheimer's biomarker research.

Alamar Biosciences has partnered with leading U.S. universities to launch a nationwide proteomics study analyzing around 21,000 plasma samples from 10,000 Alzheimer's and related dementia patients. Using its NULISAseq™ Neuro 220 test kit, the project...

Market News
Bullish
3 hours ago
Alamar Biosciences launches national study analyzing 21,000 plasma samples to advance Alzheimer's biomarkers.

Alamar Biosciences launches national study analyzing 21,000 plasma samples to advance Alzheimer's biomarkers.

Alamar Biosciences has partnered with top U.S. research universities to start a nationwide proteomics project using its NULISAseq™ Neuro 220 panel. The study will analyze about 21,000 plasma samples from 10,000 Alzheimer's and related dementia partic...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App